Identification and characterization of eukaryotic initiation factor 5A-2
- PMID: 14622290
- DOI: 10.1046/j.1432-1033.2003.03806.x
Identification and characterization of eukaryotic initiation factor 5A-2
Abstract
The phylogenetically conserved eukaryotic translation initiation factor 5A (eIF5A) is the only known cellular protein to contain the post-translationally derived amino acid hypusine [Nepsilon-(4-amino-2-hydroxybutyl)lysine]. Both eIF5A and its hypusine modification are essential for sustained cell proliferation. Normally only one eIF5A protein is expressed in human cells. Recently, we identified a second human EIF5A gene that would encode an isoform (eIF5A-2) of 84% sequence identity. Overexpression of eIF5A-2 mRNA in certain human cancer cells, in contrast to weak normal expression limited to human testis and brain, suggests EIF5A2 as a potential oncogene. However, eIF5A-2 protein has not been described in human or mammalian cells heretofore. Here, we describe the identification of eIF5A-2 protein in human colorectal and ovarian cancer lines, SW-480 and UACC-1598, that overexpress eIF5A-2 mRNAs. Functional characterization of the human isoforms revealed that either human EIF5A gene can complement growth of a yeast strain in which the yeast EIF5A genes were disrupted. This indicates functional similarity of the human isoforms in yeast and suggests that eIF5A-2 has an important role in eukaryotic cell survival similar to that of the ubiquitous eIF5A-1. Detectable structural differences were also noted, including lack of immunological cross-reactivity, formation of different complexes with deoxyhypusine synthase, and Km values (1.5 +/- 0.2 vs. 8.3 +/- 1.4 microm for eIF5A-1 and -2, respectively) as substrates for deoxyhypusine synthase in vitro. These physical characteristics and distinct amino acid sequences in the C-terminal domain together with differences in gene expression patterns imply differentiated, tissue-specific functions of the eIF5A-2 isoform in the mammalian organism and in cancer.
Similar articles
-
Mutational analyses of human eIF5A-1--identification of amino acid residues critical for eIF5A activity and hypusine modification.FEBS J. 2008 Jan;275(1):44-58. doi: 10.1111/j.1742-4658.2007.06172.x. Epub 2007 Dec 6. FEBS J. 2008. PMID: 18067580 Free PMC article.
-
Molecular cloning of bovine eIF5A and deoxyhypusine synthase cDNA.DNA Seq. 2004 Feb;15(1):26-32. doi: 10.1080/10425170310001652174. DNA Seq. 2004. PMID: 15354351
-
The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A).J Biochem. 2006 Feb;139(2):161-9. doi: 10.1093/jb/mvj034. J Biochem. 2006. PMID: 16452303 Free PMC article. Review.
-
Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme.Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):51-6. doi: 10.1073/pnas.0509348102. Epub 2005 Dec 21. Proc Natl Acad Sci U S A. 2006. PMID: 16371467 Free PMC article.
-
Functional significance of eIF5A and its hypusine modification in eukaryotes.Amino Acids. 2010 Feb;38(2):491-500. doi: 10.1007/s00726-009-0408-7. Epub 2009 Dec 8. Amino Acids. 2010. PMID: 19997760 Free PMC article. Review.
Cited by
-
The nuclear protein UHRF2 is a direct target of the transcription factor E2F1 in the induction of apoptosis.J Biol Chem. 2013 Aug 16;288(33):23833-43. doi: 10.1074/jbc.M112.447276. Epub 2013 Jul 5. J Biol Chem. 2013. PMID: 23833190 Free PMC article.
-
Overexpression of EIF5A2 Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.Diagnostics (Basel). 2020 Jun 27;10(7):436. doi: 10.3390/diagnostics10070436. Diagnostics (Basel). 2020. PMID: 32605067 Free PMC article.
-
Eukaryotic initiation factor 5A2 and human digestive system neoplasms.World J Gastrointest Oncol. 2019 Jun 15;11(6):449-458. doi: 10.4251/wjgo.v11.i6.449. World J Gastrointest Oncol. 2019. PMID: 31236196 Free PMC article. Review.
-
Expression of eukaryotic translation initiation factor 5A-2 (eIF5A-2) associated with poor survival in gastric cancer.Tumour Biol. 2016 Jan;37(1):1189-95. doi: 10.1007/s13277-015-3894-0. Epub 2015 Aug 18. Tumour Biol. 2016. PMID: 26282002
-
Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.Retrovirology. 2009 Oct 13;6:90. doi: 10.1186/1742-4690-6-90. Retrovirology. 2009. PMID: 19825182 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases